» Articles » PMID: 36235003

Recent Advances in Mass Spectrometry-Based Structural Elucidation Techniques

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2022 Oct 14
PMID 36235003
Authors
Affiliations
Soon will be listed here.
Abstract

Mass spectrometry (MS) has become the central technique that is extensively used for the analysis of molecular structures of unknown compounds in the gas phase. It manipulates the molecules by converting them into ions using various ionization sources. With high-resolution MS, accurate molecular weights (MW) of the intact molecular ions can be measured so that they can be assigned a molecular formula with high confidence. Furthermore, the application of tandem MS has enabled detailed structural characterization by breaking the intact molecular ions and protonated or deprotonated molecules into key fragment ions. This approach is not only used for the structural elucidation of small molecules (MW < 2000 Da), but also crucial biopolymers such as proteins and polypeptides; therefore, MS has been extensively used in multiomics studies for revealing the structures and functions of important biomolecules and their interactions with each other. The high sensitivity of MS has enabled the analysis of low-level analytes in complex matrices. It is also a versatile technique that can be coupled with separation techniques, including chromatography and ion mobility, and many other analytical instruments such as NMR. In this review, we aim to focus on the technical advances of MS-based structural elucidation methods over the past five years, and provide an overview of their applications in complex mixture analysis. We hope this review can be of interest for a wide range of audiences who may not have extensive experience in MS-based techniques.

Citing Articles

Serum -Glycan Profiling of Patients with Narcolepsy Type 1 Using LC-MS/MS.

Sanni A, Hakim M, Goli M, Adeniyi M, Talih F, Lanuzza B ACS Omega. 2024; 9(30):32628-32638.

PMID: 39100283 PMC: 11292663. DOI: 10.1021/acsomega.4c01593.


Structural Diversity and Biological Activity of Cyanopeptolins Produced by CCNP1411.

Konkel R, Ceglowska M, Szubert K, Wieczerzak E, Iliakopoulou S, Kaloudis T Mar Drugs. 2023; 21(10).

PMID: 37888443 PMC: 10608790. DOI: 10.3390/md21100508.


Prediction of a Large-Scale Database of Collision Cross-Section and Retention Time Using Machine Learning to Reduce False Positive Annotations in Untargeted Metabolomics.

Lenski M, Maallem S, Zarcone G, Garcon G, Lo-Guidice J, Antherieu S Metabolites. 2023; 13(2).

PMID: 36837901 PMC: 9962007. DOI: 10.3390/metabo13020282.

References
1.
Huo B, Zhang W, Zhao X, Dong H, Yu Y, Wang J . A triarylphosphine-trimethylpiperidine reagent for the one-step derivatization and enrichment of protein post-translational modifications and identification by mass spectrometry. Chem Commun (Camb). 2018; 54(98):13790-13793. DOI: 10.1039/c8cc08416e. View

2.
Lubes G, Goodarzi M . GC-MS based metabolomics used for the identification of cancer volatile organic compounds as biomarkers. J Pharm Biomed Anal. 2017; 147:313-322. DOI: 10.1016/j.jpba.2017.07.013. View

3.
Richardson K, Langridge D, Dixit S, Ruotolo B . An Improved Calibration Approach for Traveling Wave Ion Mobility Spectrometry: Robust, High-Precision Collision Cross Sections. Anal Chem. 2021; 93(7):3542-3550. DOI: 10.1021/acs.analchem.0c04948. View

4.
Klein D, Brodbelt J . Structural Characterization of Phosphatidylcholines Using 193 nm Ultraviolet Photodissociation Mass Spectrometry. Anal Chem. 2017; 89(3):1516-1522. PMC: 5480246. DOI: 10.1021/acs.analchem.6b03353. View

5.
Jora M, Burns A, Ross R, Lobue P, Zhao R, Palumbo C . Differentiating Positional Isomers of Nucleoside Modifications by Higher-Energy Collisional Dissociation Mass Spectrometry (HCD MS). J Am Soc Mass Spectrom. 2018; 29(8):1745-1756. PMC: 6062210. DOI: 10.1007/s13361-018-1999-6. View